Evaluation of a 12‐Hour Sustained‐Release Acetaminophen (Paracetamol) Formulation: A Randomized, 3‐Way Crossover Pharmacokinetic and Safety Study in Healthy Volunteers

Acetaminophen (paracetamol) is a first‐line treatment for mild and moderate pain. A twice‐daily sustained‐release (SR) formulation may be more convenient for chronic users than standard immediate‐release (IR) acetaminophen. This randomized, 3‐way crossover study evaluated pharmacokinetics and safety...

Descripción completa

Detalles Bibliográficos
Autores principales: Yue, Yong, Collaku, Agron, Liu, Dongzhou J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6084333/
https://www.ncbi.nlm.nih.gov/pubmed/28816026
http://dx.doi.org/10.1002/cpdd.367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6084333/
https://www.ncbi.nlm.nih.gov/pubmed/28816026
http://dx.doi.org/10.1002/cpdd.367

Ejemplares similares